Accellent Inc. Announces Third Quarter 2012 Results
WILMINGTON, Mass.--(BUSINESS WIRE)-- Accellent Inc. (the "Company" or "Accellent"), a wholly owned subsidiary of Accellent Holdings Corp., today announced results for its fiscal third quarter ended September 30, 2012.
Third Quarter 2012 Financial Results
Net sales were $126.0 million in the third quarter of 2012 compared with $126.8 million in the third quarter of 2011. Income from continuing operations was $16.2 million in the third quarter of 2012, compared with $13.3 million in the third quarter of 2011. Net loss was $6.5 million in the third quarter of 2012 compared to $4.4 million in the third quarter of 2011.
Adjusted EBITDA in the third quarter of 2012 was $28.3 million, or 22.4% of net sales, compared to Adjusted EBITDA of $24.3 million, or 19.2% of net sales, in the third quarter of 2011.
"Despite on-going revenue challenges, we continued to improve our business fundamentals that drive sustainable profitable growth. In the third quarter, despite relatively flat sales, Adjusted EBITDA increased over 16% year over year. I am optimistic that our actions will continue to generate positive results" stated Donald Spence, President and CEO of Accellent.
Nine Months Ended September 30, 2012 Financial Results
Net sales decreased 2.1% to $376.5 million in the first nine months of 2012 compared with $384.5 million in the first nine months of 2011. Income from continuing operations was $39.8 million in the first nine months of 2012 compared with $44.5 million in the first nine months of 2011. Net loss was $19.1 million in the first nine months of 2012 compared with a net loss of $11.6 million in the first nine months of 2011.
Adjusted EBITDA for the first nine months of 2012 was $76.7 million, or 20.4% of net sales compared to Adjusted EBITDA of $77.1 million, or 20.0% of net sales in the first nine months of 2011.
Reconciliations of non-GAAP financial measures to GAAP financial measures are provided in the financial information accompanying this press release.
The financial information included in this press release reflect results from continuing operations for all periods presented and assets to be held and used. Results of discontinued operations and assets held for sale are presented separately for all periods presented.
Donald Spence, President and Chief Executive Officer, and Jeremy A. Friedman, Executive Vice President and Chief Financial Officer, will discuss our third quarter financial results in a conference call scheduled for today, November 8, 2012 at 5 p.m. Eastern Standard Time. The teleconference can be accessed live on the Internet through the Investor Relations section of the Accellent website at www.accellent.com or by calling (800) 446-1671 pass code 33716271. Please visit the website or dial in 10 to 15 minutes prior to the beginning of the call to download and install any necessary audio software. A replay of the conference call will be available via www.accellent.com or by telephone at (888) 843-7419 pass code 33716271 until November 15, 2012.
Accellent Holdings Corp., through its wholly owned subsidiary Accellent, Inc., provides fully integrated outsourced manufacturing and engineering services to the medical device industry primarily in the cardiology, endoscopy and orthopedic markets. Accellent has broad capabilities in precision component fabrication, finished device assembly, complete supply chain management capabilities and engineering services. These capabilities enhance customers' speed to market and return on investment by enabling them to refocus internal resources more efficiently. For more information, please visit www.accellent.com.
This press release includes "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Act of 1934, as amended. All statements included herein, other than statements of historical fact, may constitute forward-looking statements. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to be correct. Important factors that could cause actual results to differ materially from the Company's expectations are disclosed in the risk factors contained in the Company's Form 10-K for the year ended December 31, 2011 filed with the Securities and Exchange Commission on March 29, 2012. All forward-looking statements are expressly qualified in their entirety by such risk factors.
|Unaudited Condensed Consolidated Statements of Operations|
|Three Months Ended||Nine Months Ended|
|Cost of sales (exclusive of amortization)||95,014||92,250||284,056||280,370|
|Selling, general and administrative expenses||14,165||12,833||42,677||41,502|
|Research and development expenses||602||419||2,081||1,364|
|Loss (gain) on disposal of assets||6||(221||)||53||(254||)|
|Amortization of intangible assets||3,735||3,735||11,205||11,205|
|Total operating expenses||18,508||17,480||56,016||56,369|
|Income from continuing operations||13,318||16,231||44,458||39,787|
|Other (expense) income, net:|
|Interest expense, net||(17,232||)||(17,379||)||(51,660||)||(51,879||)|
|Other income (expense), net||1,247||592||(1,403||)||(90||)|
|Total other (expense) income, net||(15,985||)||(16,787||)||(53,063||)||(51,969||)|
|Loss from continuing operations before income taxes||(2,667||)||(556||)||(8,605||)||(12,182||)|
|Provision for income taxes||1,853||1,110||3,898||3,233|
|Net loss from continuing operations||(4,520||)||(1,666||)||(12,503||)||(15,415||)|
|Income (loss) from discontinued operations, net of tax||121||(4,814||)||944||(3,659||)|
|Unaudited Condensed Consolidated Balance Sheets|
Accounts receivable, net of allowances of $1,983 and $1,904 as of December 31, 2011 and
|Assets held for sale, current portion||3,874||1,767|
|Prepaid expenses and other current assets||4,416||5,320|
|Total current assets||164,064||177,854|
|Property, plant and equipment, net||121,153||116,555|
|Long-term assets held for sale||16,250||6,019|
|Other intangible assets, net||149,687||138,482|
|Deferred financing costs and other assets, net||16,825||14,635|
|Liabilities and Stockholder's equity|
|Current portion of long-term debt||$||22||$||15|
|Accrued payroll and benefits||7,858||10,531|
|Liabilities held for sale, current portion||1,908||972|
|Accrued expenses and other current liabilities||18,747||16,086|
|Total current liabilities||69,089||69,857|
Common stock, par value $0.01 per share, 50,000,000 shares authorized; 1,000 shares issued
|Additional paid-in capital||638,445||638,980|
|Accumulated other comprehensive (loss)||(1,266||)||(965||)|
|Total stockholder's equity||266,900||248,663|
|Total liabilities and stockholder's equity||$||1,087,422||$||1,072,988|